“…found depression the most important predictor of poor treatment adherence (Gonzales et al, 2011;Rutakumwa et al, 2021), low health-related quality of life (Pérez-Chaparro et al, 2022;Rzeszutek & Gruszczyńska, 2018), faster HIV infection progression, and even increasing mortality in this patient group (Ickovicks et al, 2001;Namagga et al, 2021). However, the aetiology of depression is very complex, and various biological and psychosocial factors co-occur as risk factors in this clinical sample, including potentially terminal diagnosis (Filiatreau et al, 2022;Leserman, 2003), challenges with HIV disclosure and related HIV/AIDS stigma (Kiene et al, 2018;Zotova et al, 2022), and the burden of life-long treatment adherence and associated side-effects (Borran et al, 2021;Fumaz et al, 2005).…”